NCT00958035

Study of Bimatoprost Solution in Increasing Eyelash Prominence in African Americans With Eyelash Hypotrichosis

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 89 (actual)
• Sponsor: Allergan · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study will evaluate the safety and efficacy of bimatoprost solution 0.03% once daily to the upper eyelid margins (where the eyelashes meet the skin) compared with vehicle in increasing overall eyelash prominence in self-identified African American/ethnic black subjects exhibiting hypotrichosis of the eyelashes (inadequate or not enough eyelashes).

Conditions

• Hypotrichosis

Interventions

Type	Name	Description
DRUG	bimatoprost ophthalmic 0.03% solution	Apply one drop of study medication along the upper eyelid margin once daily in the evening
DRUG	vehicle sterile solution (placebo)	Apply one drop of study medication along the upper eyelid margin once daily in the evening

Timeline

• Start date: 2009-11-01
• Primary completion: 2010-07-01
• Completion: 2010-08-01
• First posted: 2009-08-13
• Last updated: 2012-01-05
• Results posted: 2012-01-05

Locations

1 site across 1 country: United States